Michael S Denison Selected Research

Michael S Denison Research Topics

Disease

14	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 01/2002
8	Neoplasms (Cancer) 12/2019 - 07/2002
7	Breast Neoplasms (Breast Cancer) 01/2017 - 12/2002
4	Carcinoma (Carcinomatosis) 10/2016 - 06/2002
3	Inflammation (Inflammations) 01/2021 - 07/2014
2	Skin Diseases (Skin Disease) 04/2022 - 08/2013
2	Melanoma (Melanoma, Malignant) 12/2019 - 11/2018
2	Adrenocortical Carcinoma 01/2016 - 11/2004
2	Carcinogenesis 04/2015 - 01/2010
2	Hypoxia (Hypoxemia) 11/2011 - 01/2007
2	Pneumonia (Pneumonitis) 08/2011 - 08/2008
1	Skin Neoplasms (Skin Cancer) 04/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Chronic Renal Insufficiency 01/2018
1	Colonic Neoplasms (Colon Cancer) 01/2017
1	Osteosarcoma (Osteogenic Sarcoma) 01/2017
1	Breast Diseases (Breast Disease) 01/2016
1	Infections 07/2014
1	Prostatic Neoplasms (Prostate Cancer) 06/2013
1	Necrosis 01/2013
1	Hyperplasia 08/2011
1	Chronic Obstructive Pulmonary Disease (COPD) 08/2011

Drug/Important Bio-Agent (IBA)

13	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 04/2022 - 06/2002
8	Polychlorinated Dibenzodioxins (TCDD)IBA 01/2021 - 01/2002
8	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 01/2021 - 01/2006
7	DioxinsIBA 01/2021 - 04/2005
6	LuciferasesIBA 01/2021 - 07/2002
6	Estrogens (Estrogen)FDA Link 10/2016 - 06/2002
6	LigandsIBA 04/2015 - 02/2002
5	Messenger RNA (mRNA)IBA 08/2015 - 01/2006
4	Estrogen ReceptorsIBA 01/2021 - 12/2002
4	Proteins (Proteins, Gene)FDA Link 08/2020 - 01/2007
3	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 08/2015 - 09/2011
2	Polychlorinated Biphenyls (PCBs)IBA 01/2021 - 04/2005
2	CytochromesIBA 01/2021 - 04/2015
2	AndrogensIBA 10/2016 - 01/2013
2	HexanesIBA 10/2016 - 02/2016
2	AcetoneIBA 10/2016 - 02/2016
2	Aromatase (CYP19)IBA 01/2016 - 11/2004
2	anthraceneIBA 04/2015 - 01/2009
2	Anthocyanins (Anthocyanin)IBA 07/2013 - 04/2013
2	Biological ProductsIBA 06/2013 - 08/2008
2	Phytoestrogens (Phytoestrogen)IBA 06/2013 - 05/2012
2	FlavonoidsIBA 11/2004 - 07/2002
2	enhanced green fluorescent proteinIBA 02/2002 - 01/2002
1	Androgen Receptors (Androgen Receptor)IBA 01/2021
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2021
1	Interleukin-8 (Interleukin 8)IBA 01/2021
1	XenobioticsIBA 01/2021
1	SolventsIBA 01/2021
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2021
1	Genetic Markers (Genetic Marker)IBA 01/2021
1	VemurafenibIBA 12/2019
1	Phosphotransferases (Kinase)IBA 11/2018
1	Transcription Factors (Transcription Factor)IBA 11/2018
1	HydrocarbonsIBA 11/2018
1	ResveratrolIBA 11/2018
1	Uremic ToxinsIBA 01/2018
1	nasIBA 01/2017
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2017
1	Adenosine Triphosphate (ATP)IBA 01/2017
1	AcidsIBA 01/2017
1	Hydroxyl RadicalIBA 01/2017
1	NeonicotinoidsIBA 01/2016
1	AtrazineIBA 01/2016
1	Hormones (Hormone)IBA 01/2016
1	ThiamethoxamIBA 01/2016
1	thiaclopridIBA 01/2016
1	imidaclopridIBA 01/2016
1	Pregnane X ReceptorIBA 12/2015
1	EnzymesIBA 08/2015
1	Metformin (Glucophage)FDA LinkGeneric 04/2015
1	8-hydroxyguanineIBA 04/2015
1	AntioxidantsIBA 04/2015
1	CarcinogensIBA 04/2015
1	Pharmaceutical PreparationsIBA 04/2015
1	DNA AdductsIBA 04/2015
1	DNA Glycosylases (DNA Glycosylase)IBA 04/2015
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 07/2014
1	EndotoxinsIBA 07/2014
1	pelargonidinIBA 04/2013
1	petunidinIBA 04/2013
1	cyanidinIBA 04/2013
1	delphinidinIBA 04/2013
1	peonidinIBA 04/2013
1	malvidinIBA 04/2013
1	icaritinIBA 05/2012
1	Estradiol (Delestrogen)FDA LinkGeneric 05/2012
1	Small Interfering RNA (siRNA)IBA 05/2012
1	Estrogen Receptor alphaIBA 05/2012
1	harmalolIBA 02/2012
1	HarmalineIBA 02/2012
1	harmolIBA 01/2012
1	Harmine (Telepathine)IBA 01/2012
1	p38 Mitogen-Activated Protein KinasesIBA 09/2011
1	SB 203580IBA 09/2011
1	Particulate MatterIBA 08/2011
1	Triglycerides (Triacylglycerol)IBA 01/2009

Therapy/Procedure

1	Drug Tapering 12/2019
1	Therapeutics 12/2019